Lymphedema: Pathophysiology and clinical manifestations.
Grada AA, Phillips TJ.
J Am Acad Dermatol. 2017 Dec;77(6):1009-1020. doi: 10.1016/j.jaad.2017.03.022.
[Management of secondary lymphedema in patients with cancer].
Wenczl E.
Orv Hetil. 2016 Mar 27;157(13):488-94. doi: 10.1556/650.2016.30390.
Lymphedema.
Rockson SG.
Am J Med. 2001 Mar;110(4):288-95. doi: 10.1016/s0002-9343(00)00727-0.
[Surgical therapy of secondary elephantoid lymphedema of the eyelids].
Sandner A, Lindner A.
HNO. 2015 Jan;63(1):56-9. doi: 10.1007/s00106-013-2769-1.
[Lymphedema].
Becker F.
Rev Med Suisse. 2006 Feb 1;2(51):323-4, 327-9.
[Secondary malignant lymphedema].
Soucek-Hadwiger B, Döller W.
Wien Med Wochenschr. 2006 May;156(9-10):309-13. doi: 10.1007/s10354-006-0296-3.
Cancer-associated secondary lymphoedema.
Rockson SG, Keeley V, Kilbreath S, Szuba A, Towers A.
Nat Rev Dis Primers. 2019 Mar 28;5(1):22. doi: 10.1038/s41572-019-0072-5.
Current status of selenium and other treatments for secondary lymphedema.
Bruns F, Micke O, Bremer M.
J Support Oncol. 2003 Jul-Aug;1(2):121-30.
[Secondary lymphedema in gynecologic neoplasms].
Lotze W, Richter P.
Zentralbl Gynakol. 1989;111(2):92-8.
Cancer-associated secondary lymphoedema.
[No authors listed]
Nat Rev Dis Primers. 2019 Mar 28;5(1):23. doi: 10.1038/s41572-019-0078-z.
